P930036S012

None

FDA Premarket Approval P930036 S012

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP930036S012
Classification NameNone
Applicant
PMAP930036
SupplementS012

Supplemental Filings

Supplement NumberDateSupplement Type
P930036Original Filing
S020 2022-09-01 30-day Notice
S019 2022-03-22 30-day Notice
S018 2021-08-11 Real-time Process
S017 2021-07-26 30-day Notice
S016 2021-04-01 30-day Notice
S015 2020-07-31 30-day Notice
S014 2020-03-09 30-day Notice
S013 2020-02-21 30-day Notice
S012
S011 2019-02-01 30-day Notice
S010 2018-12-06 Normal 180 Day Track
S009 2018-07-27 Real-time Process
S008 2017-09-01 Normal 180 Day Track
S007 2016-10-20 135 Review Track For 30-day Notice
S006 2015-07-17 Normal 180 Day Track
S005 2012-03-26 Normal 180 Day Track No User Fee
S004 2012-02-15 135 Review Track For 30-day Notice
S003 2005-07-22 Real-time Process
S002 2002-01-16 Real-time Process
S001 1998-05-01 Real-time Process

NIH GUDID Devices

Device IDPMASupp
00630414597720 P930036 001
00630414124797 P930036 001
00630414124933 P930036 001
00630414124940 P930036 001
00630414126319 P930036 001
00630414177328 P930036 001
00630414177335 P930036 001
00630414022963 P930036 001
00630414238791 P930036 008
00630414238807 P930036 008

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.